Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;36(10):2135-2144.
doi: 10.1007/s10815-019-01551-5. Epub 2019 Aug 9.

Biphasic in vitro maturation (CAPA-IVM) specifically improves the developmental capacity of oocytes from small antral follicles

Flor Sanchez  1   2 , Anh H Le  3   4 , Vu N A Ho  3   4 , Sergio Romero  1   2 , Heidi Van Ranst  1 , Michel De Vos  1 , Robert B Gilchrist  5 , Tuong M Ho  3   4 , Lan N Vuong  3   4   6 , Johan Smitz  7
Affiliations

Biphasic in vitro maturation (CAPA-IVM) specifically improves the developmental capacity of oocytes from small antral follicles

Flor Sanchez et al. J Assist Reprod Genet. 2019 Oct.

Abstract

Purpose: To investigate the effectiveness of a biphasic IVM culture strategy at improving IVM outcomes in oocytes from small follicles (< 6 mm) compared with routine Standard IVM in patients with polycystic ovaries.

Methods: This prospective pilot study was performed in 40 women with polycystic ovaries whose oocytes were randomized to two IVM culture methods. Patients received a total stimulation dose of 450 IU rFSH. Cumulus-oocyte complexes (COCs) from follicles < 6 mm and ≥ 6 mm were retrieved and cultured separately in either a prematuration medium with c-type natriuretic peptide followed by IVM (CAPA-IVM), or STD-IVM. Primary outcomes were maturation rate, embryo quality, and the number of vitrified day 3 embryos per patient.

Results: Use of the CAPA-IVM system led to a significant improvement in oocyte maturation (p < 0.05), to a doubling in percentage of good and top-quality day 3 embryos per COC, and to an increased number of vitrified day 3 embryos (p < 0.001), compared to STD IVM. Oocytes from follicles < 6 mm benefited most from CAPA-IVM, showing a significant increase in the amount of good and top-quality embryos compared to STD IVM. CAPA-IVM yielded significantly (p < 0.0001) less GV-arrested oocytes and larger oocyte diameters (p < 0.05) than STD IVM.

Conclusions: CAPA-IVM brings significant improvements in maturation and embryological outcomes, most notably to oocytes from small antral follicles (< 6 mm), which can be easily retrieved from patients with a minimal ovarian stimulation. The study demonstrates the robustness and transferability of the CAPA-IVM method across laboratories and populations.

Keywords: C-type natriuretic peptide; Embryo; IVF; IVM; Oocyte prematuration.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
Representative scheme showing the clinical protocol applied and the key steps following oocyte retrieval. The stimulation protocol used was similar for the two different groups of IVM systems
Fig. 2
Fig. 2
Representative images of cumulus-oocyte complexes immediately after oocyte retrieval (left panel) and after undergoing the CAPA-IVM system. The figure shows a group of COCs < 6 mm from a single patient exposed to 24 h CAPA culture (post CAPA, middle panel) followed by 30 h IVM (post CAPA-IVM, panel on the right). Scale bar 200 μm
Fig. 3
Fig. 3
Representative example of a pool of COCs after retrieval (left panel), with an oocyte that is only partially surrounded by cumulus cells (arrow). In the middle panel are COCs after CAPA culture. In the right panel a fully expanded COC is shown and an oocyte that has become totally disconnected from cumulus cells (arrow) after incubation in CAPA-IVM
See this image and copyright information in PMC

References

    1. Trounson A, Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril. 1994;62:353–362. - PubMed
    1. De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet. 2014;384:1302–1310. - PMC - PubMed
    1. Segers I, Mateizel I, Van Moer E, Smitz J, Tournaye H, Verheyen G, et al. In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising “ex vivo”; method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe. J Assist Reprod Genet. 2015;32:1221–1231. - PMC - PubMed
    1. Fasano G, Dechène J, Antonacci R, Biramane J, Vannin AS, Van Langendonckt A, Devreker F, Demeestere I. Outcomes of immature oocytes collected from ovarian tissue for cryopreservation in adult and prepubertal patients. Reprod BioMed Online. 2017;34:575–558. - PubMed
    1. Gremeau AS, Andreadis N, Fatum M, Craig J, Turner K, Mcveigh E, Child T. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case–control study of 194 treatment cycles. Fertil Steril. 2012;98:355–360. - PubMed

Substances